Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.bloomberg.com › news › articlesLilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal

    Hace 22 horas · Eli Lilly & Co. agreed to buy U.S. gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some of the proceeds from obesity blockbuster Zepbound into its experimental pipeline.

  2. www.expertoanimal.com › animales-de-la-pelicula-madagascar-26881+30 Animales de la película Madagascar - Nombres y fotos REALES

    1 de jul. de 2024 · Animales de la película Madagascar. Alex es un león, Marty una cebra, Melman una jirafa, Gloria un hipopótamo, el Rey Julien un lémur de cola anillada y Skipper un pingüino. ¡Conoce más personajes!

  3. seekingalpha.com › news › 4122514-eli-lilly-to-acquire-morphic-for-57-a-share-in-cashEli Lilly to acquire Morphic for $57 a share in cash (NYSE:LLY)

    Hace 23 horas · In a bid to strengthen its immunology pipeline, Eli Lilly (NYSE:LLY) on Monday announced a deal to acquire biopharmaceutical company Morphic Holding (NASDAQ:MORF) for $57 a share in cash, or an ...

  4. markets.businessinsider.com › news › stocksWhy Is Morphic (MORF) Stock Up 75% Today? | Markets Insider

    Hace 1 día · MORF stock is up 75.1% as of Monday morning. Investors will find more of the most recent stock market stories below! We have all of the hottest stock market news available on Monday!

  5. www.tomatazos.com › peliculas › 881001Película: IntensaMente 2 (Inside Out 2) - Tomatazos

    14 de jun. de 2024 · La película de Disney y Pixar INTENSA-MENTE 2 regresa a la mente de la recién adolescente Riley justo cuando el cuartel general está sufriendo una repentina demolición para hacer sitio a algo totalmente inesperado: ¡nuevas emociones!

  6. investor.lilly.com › news-releases › news-release-detailsLilly to Acquire Morphic to Improve Outcomes for Patients with...

    Hace 1 día · Acquisition to expand Lilly's immunology pipeline with oral integrin therapies . INDIANAPOLIS and WALTHAM, Mass., July 8, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF) today announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases.

  7. www.benzinga.com › general › biotechEli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease...

    Hace 1 día · Eli Lilly to acquire Morphic Holding Inc for $3.2 billion, strengthening its portfolio in chronic disease treatments. Morphic's lead program, MORF-057, targets inflammatory bowel disease, with ...